Medical device comprising adhesive pad

Information

  • Patent Grant
  • 9254373
  • Patent Number
    9,254,373
  • Date Filed
    Friday, December 18, 2009
    14 years ago
  • Date Issued
    Tuesday, February 9, 2016
    8 years ago
Abstract
The invention relates to an adhesive pad and a surface plate which in combination can provide a medical device which is to be placed on the skin of a patient. The combined medical device is provided with a subcutaneous part which necessitates that the device is securely and comfortably attached to the patient's skin. Often such devices are used to transfer medication such as insulin to a patient from a reservoir. An embodiment according to the invention relates to a medical device comprising—a cannula (22) or another part to be positioned subcutaneously when in use,—a surface plate (1) provided with a contact surface and with an opening (12B) through which the cannula (22) or another subcutaneously positioned part passes when the medical device is in use, and—an adhesive pad (2) secured to the contact surface of the surface plate (1) providing adhesion of the surface plate (1) to a skin surface which adhesive pad (2) comprises—a first surface facing the contact surface and having areas unreleasably secured to the contact surface by welding, and—a second surface facing the skin of a patient during use and having areas provided with a skin compatible adhesive which can be releasably secured to the skin of a patient wherein an adhesive part (30) has been placed between the contact surface of the surface plate (1) and the first surface of the adhesive pad (2) in an area where the two surfaces have not been welded together thereby securing these unwelded areas of the contact surface to the first surface.
Description

This application claims the benefit under 35 U.S.C. §371 of International Application No. PCT/EP2009/067490, filed Dec. 18, 2009, which claims the benefit of Danish Application No. PA 2008 01833, filed Dec. 22, 2008 and U.S. Provisional Application Ser. No. 61/139,833, filed Dec. 22, 2008, which are incorporated by reference herein in their entirety.


THE TECHNICAL FIELD

The invention relates to an adhesive pad and a surface plate which in combination can provide a medical device which is to be placed on the skin of a patient. The combined medical device is provided with a subcutaneous part which necessitates that the device is securely and comfortably attached to the patient's skin. Often such devices are used to transfer medication such as insulin to a patient from a reservoir.


PRIOR ART

Traditionally adhesive pads are secured to a medical device such as an infusion set by welding. Welding is highly efficient and it would not be possible to remove the adhesive pad from the medical device after the adhesive pad has been welded on to the medical device without destroying at least the adhesive pad.


WO 2006/061354 relates to a medical device comprising a transcutaneous device unit and a process unit. The transcutaneous device unit is adapted to be mounted to a skin surface of a subject and comprises a first housing, a transcutaneous device, and may comprise a flexible patch portion with an upper surface and a lower mounting surface adapted for application to the skin of a subject. The process unit comprises a second housing with a lower surface and a process assembly. The first and second housings are adapted to be secured to each other in such a way that the lower surface of the second housing is allowed to move freely relative to at least a portion of the underlying skin surface or patch. In this way a relatively flexible patch portion can adapt to the skin surface to which it is mounted both statically and dynamically without being restricted in its movements by the normally much stiffer process unit. The flexible patch portion comprise a flexible sheet (12) and a flexible support plate (11) extending from the housing, the support plate further comprises a flexible reidge formed support member (13) extending from the housing. The support plate (11) as well as the housing may be fully or partly attached to the flexible sheet e.g. by welding or adhesives.


It is though a problem that welding destroys the ability to adhere on the adhesive surface of the adhesive pad, i.e. the surface which is facing the skin of the patient after having mounted the medical device, in those areas where welding has taken place. Therefore welding is a balance between welding areas enough to secure the adhesive pad adequately to the medical device and leaving an adhesive area large enough to allow the adhesive pad to adhere adequately to the patient. The adhesive pad is considered to adhere adequately when the medical device is kept in place without moving; especially should any subcutaneously inserted parts such as cannulas or sensors be kept completely stationary until the user decides to remove the device.


One way to solve this problem is to increase the general area of the adhesive pad i.e. use an adhesive pad which is considerably larger than the surface of the medical device facing the adhesive pad. However, this approach is most convenient for smaller medical devices as the patients do not appreciate having large adhesive pads removed from their skin.


THE INVENTION

The object of the invention is to provide a medical device comprising a cannula (22) or another part to be positioned subcutaneously when in use, a surface plate (1) provided with a contact surface and with an opening (12B) through which the cannula (22) or another subcutaneously positioned part passes when the medical device is in use, and an adhesive pad (2) secured to the contact surface of the surface plate (1) providing adhesion of the surface plate (1) to a skin surface which adhesive pad (2) comprises a first surface facing the contact surface and having areas unreleasably secured to the contact surface by welding, and a second surface facing the skin of a patient during use and having areas provided with a skin compatible adhesive which can be releasably secured to the skin of a patient. The medical device further comprises an adhesive part (30) which has been placed between the contact surface of the surface plate (1) and the first surface of the adhesive pad (2) in an area where the two surfaces have not been welded together thereby securing these unwelded areas of the contact surface to the first surface.


One advantage of this inventive medical device is that it is possible to have an adhesive pad which fits e.g. an arm or another skin surface having a certain rounding perfectly, and at the same time having a relatively large rigid surface plate attached securely to the adhesive pad. This means that the patient carrying the device has an increased freedom in relation to where to position the device as the patient or the user of the device does not have to take the form of the skin surface into account when positioning the device but instead the patient can have the medical device positioned at a place where it is conveniently hidden by the clothes or conveniently positioned for other reasons.


The at least one adhesive part (30) further assures that the surface plate (1) and especially the subcutaneous part is kept in its desired subcutaneous position although parts of the surface plate are somehow distanced from the adhesive pad (2).


According to one embodiment the adhesive part (30) comprises a piece of double adhesive material i.e. each side of the adhesive part (30) is provided with adhesive coating or the adhesive part (30) comprises a coating of adhesive placed directly on the contact surface of the surface plate (1) or the adhesive part (30) comprises a coating of adhesive placed directly on the first surface of the adhesive pad (2).


According to a further embodiment an adhesive part (30) is positioned along the edge of the opening (12B) of the contact surface of the surface plate (1) through which opening (12B) the cannula (22) or another subcutaneously positioned part passes. According to this embodiment the portion of the surface plate (1) surrounding the subcutaneously positioned part is kept stationary relative to the adhesive pad and as the adhesive pad has its full adhesive strength in this area; this portion of the adhesive pad is kept stationary relative to the patient's skin. This prevents trauma of the patient's skin and increase the comfort for the patient.


According to a further embodiment the adhesive part (30) comprises a piece of double adhesive tape which can be sterilized by either gamma radiation or ethylene oxide gas.


According to a further embodiment the area covered by the adhesive part (30) is between 0.5-1.5 cm2. Normally the area covered by the adhesive part (30) is around 1 cm2 but the exact area depend on both the form of the adhesive part (30) and of the size of the surface plate (1) and the adhesive pad (2).


According to a further embodiment each separate welding is provided in the form of a spot welding placed on at least two opposite sides of the adhesive part (30) in order to avoid peeling i.e. separation between the surface plate 1 and the adhesive pad 2. The spot weldings are placed relatively close to the adhesive part (30) i.e. within 10 mm from the edge of the adhesive part (30).


According to a further embodiment a welding is also placed between the adhesive part (30) and at least one edge of the surface plate 1 in order to avoid that the surface plate 1 pivots away from the adhesive pad 2 and thereby cause and inconvenience to the patient. The welding can e.g. be placed between the adhesive part (30) and at least one edge of the surface plate 1 comprising either a larger circular welding as shown in FIG. 2A-2) or several spot weldings as shown in FIG. 2E-2G.


According to a further embodiment the subcutaneously positioned part is a sensor e.g. the sensor can register the content of glucose in the blood of the patient.


A further object of the invention is to provide a base part comprising a surface plate (1) provided a contact surface and having an opening (12B) through which a cannula (22) or another subcutaneously positioned part passes when the medical device is in use, and an adhesive pad (2) secured to the contact surface of the surface plate (1) providing adhesion of the surface plate (1) to a skin surface which adhesive pad comprises a first surface facing the contact surface and having areas unreleasably secured to the contact surface by welding, and a second surface facing the skin of a patient during use and having areas provided with a skin compatible adhesive which can be releasably secured to the skin of a patient. Further, an adhesive part (30) has been placed between the contact surface of the surface plate (1) and the first surface of the adhesive pad (2) in an area where the two surfaces has not been welded together thereby optimizing the adherence between these unwelded areas of the contact surface to the first surface. “Optimizing” means that the surface plate is thoroughly secured to the adhesive pad while at the same time the surface plate can move in relation to the adhesive pad.


A further object of the invention is to provide an adhesive pad secured to a medical device and providing adhesion of the medical device to a skin surface which adhesive pad comprises a first surface facing the medical device having areas unreleasably secured to the medical device by welding, and a second surface having areas provided with a skin compatible adhesive which can be releasably secured to the skin of a patient, and also the first surface has at least one area provided with an adhesive securing the first surface to the medical device. According to this embodiment the medical device can be provided with a cannula (22) and the at least one area provided with an adhesive is surrounding the point where the cannula pass through the adhesive pad (2).





DETAILED DESCRIPTION

Embodiments of the invention will now be described with reference to the figures in which:



FIG. 1A-1C shows a prior art medical device comprising a delivery part and a base part, FIG. 1A shows the device from below, FIG. 1B shows the device seen from above and 1C shows the device in and end view opposite the views of FIGS. 1A and 1B.



FIG. 2A-G show several embodiments of part of a medical device according to the invention having an approximately rectangular contact surface.



FIGS. 3A and B shows two embodiments of an adhesive pad to be used with a medical device provided with a cannula or another subcutaneously positioned part and having a contact surface facing a round adhesive pad, FIG. 3A illustrates the prior art and FIG. 3B illustrates an embodiment according to the invention.






FIGS. 1A-C show an example of a medical device which device is relatively large and heavy. The device is of a type having credit card size, being rectangular and being self contained i.e. including a delivery part and without connections to other parts as the device carry both a reservoir and pumping and controlling means while in use.


The medical device comprises a base part which when the device is in use is secured to the skin of a patient. The base part comprises a surface plate 1 and an adhesive pad 2 which adhesive pad 2 is unreleasably fastened to the surface plate 1 during manufacturing of the medical device. A connection part 3 is attached to the surface plate 1 which surface plate 1 can be constructed of a molded plastic material. The connection part 3 comprises a fluid path provided with a membrane 17 and a delivery part comprising a reservoir 6, the two parts are in a position where they are separated from each other and they are shown from different angles. In FIG. 1A the two parts are shown from below. This view shows an opening 12B through which a cannula part 7 can be inserted through the base part and through which opening 12B a cannula 22 extends. The connection part 3 is provided with a cannula opening 12A which accurately fits around a cannula part 7 when the cannula part 7 is mounted in the connection part 3 i.e. the cannula opening 12A has the same shape or profile as the cannula part 7 and is just big enough to let the cannula part 7 pass through and then fit into the opening.


The surface plate 1 has a contact surface which is defined as the surface which is in contact with the proximal or the first surface of the adhesive pad 2 which is the surface of the adhesive pad 2 facing the medical device. The contact surface of the surface plate and the first side of the adhesive pad 2 has areas unreleasably secured to each other by welding. Further the second surface of the adhesive pad 2 i.e. the surface facing the skin of the patient has areas provided with a skin compatible adhesive. Normally the full surface of the second surface will be adhesive except for the areas which have been subjected to welding when joining the surface plate 1 and the adhesive pad 2 together.


In FIG. 2B the cannula part 7 is shown in a position where the cannula part 7 is fully inserted. When the cannula part 7 is fully inserted, the upper surface i.e. the distal surface of the cannula part 7 is normally at level with or at a lower level than the outer surface of the connection part 3 around the cannula opening 12A. From this view it is possible to see how the reservoir 6 is positioned in the delivery part 8 and to see how two opposite positioned release handles 9 are placed at the edge of the delivery part 8. Further a longitudinal track corresponding to longitudinal raised guiding means 4 on the base part can be seen.


The two release handles 9 are formed as s-shaped bands where one end is fastened hinge-like to the housing of the delivery part 8 and the first curve in the s-shape is slightly extending the outer surface of the housing of the delivery part whereas the second curve is free i.e. not attached to the housing of the delivery part 8 and is provided with a hook-like shape which can fold around a part 15 protruding from the distal surface of the base part. When the delivery part is locked to the base part both release handles 9 are folded round a protruding part 15, when the delivery part 8 is to be removed from the base part, the two opposite release handles 9 are pushed together whereby the hook-like parts of the release handles 9 are released from the protruding parts 15 of the base part, and the delivery part can be moved backwards i.e. in the direction away from the cannula part 7 and removed from the base part in this direction.


In FIG. 1B the two parts are shown from above. This view shows how the delivery part 8 of this embodiment can be joined to the base part by pushing the delivery part 8 down toward the guiding means 4 which in this case is a longitudinal raised platform having e.g. a metal lining 5 fastened to the top surface. The delivery part 8 is provided with corresponding means e.g. comprising a track corresponding to the raised platform 4. The corresponding means of the delivery part 8 can slide along the metal lining 5 of the raised platform 4 of the base part in the longitudinal direction. When the delivery part 8 arrives at its working position, the two release handles 9 engage respectively with the two protruding parts 15 protruding from the upper surface of the surface plate 1. When the delivery part 8 is in its working position it is locked in any horizontal direction by the release handles 9. The locking mechanisms make it possible to fasten and release the delivery device from the base part as often as needed i.e. a single-use base part can be combined with a multi-use delivery part.


In FIG. 1C the two parts are shown from the end opposite of where the inserter was fastened before insertion of the penetrating member. From this side it is possible to see the inlet opening 13 in the connection part 3 through which e.g. medication from the reservoir 6 can enter, the inlet opening 13 is protected with a membrane to prevent contamination with microorganisms. The connection part 3 can be provided with both a connector needle (not shown as it is placed behind the bubble shaped membrane 17) and a bubble shaped self closing membrane 17 and the reservoir 6 can be provided with a bubble shaped self closing membrane. Hereby a fluid path is established providing transfer of medication e.g. insulin or nutrients from the reservoir to the connector part 3. As both parts are provided with self closing membranes it will be possible to separate the two units from each other and rejoin them at a later time without the connection part 3 and thereby the patient being contaminated.



FIGS. 2A-G show embodiments of a medical device according to the invention having an approximately rectangular contact surface embodiment attached to an adhesive pad. The adhesive pad 2 of FIG. 2A-G and the illustrated attachments can e.g. be used together with a surface plate 1 and a delivery device of the type shown in FIG. 1A-C.


The base part shown in FIG. 2A-D is a second embodiment differing from the embodiment shown in FIG. 1A-C in that e.g. the guiding means 4 of the surface plate 1 comprises two elongated bars placed along opposite sides of the base part.


As described for the known embodiment of FIG. 1 the surface plate 1 has a contact surface which is defined as the surface which is in contact with the first surface of the adhesive pad 2 which is the surface of the adhesive pad 2 facing the surface plate 1. The contact surface of the surface plate 1 and the first side of the adhesive pad 2 has areas unreleasably secured to each other by welding. Further the second surface of the adhesive pad 2 i.e. the surface facing the skin of the patient has areas provided with a skin compatible adhesive. Normally the full surface of the second surface of the adhesive pad 2 will be adhesive except for the areas which have been subjected to welding when joining the surface plate 1 and the adhesive pad 2 together as welding ruins the adhesive surface opposite the welded surfaces.



FIG. 2A-2D shows an embodiment of a base part to which it is possible to join a delivery device; the base part comprises a surface plate 1 and an adhesive part 2.



FIG. 2A shows the surface plate 1 separated from the adhesive pad 2 although the two parts will be joined together by welding during manufacturing. The welding positions 32 are shown on the surface plate 1 and can be seen in FIGS. 2B, 2C and 2D where the surface plate 1 is seen from below. A first welding position is placed around the opening 12B through which the cannula part 7 enters. The welding is placed in a minimum distance from the cannula opening 12B in order assure that the welding will not ruin the ability of the adhesion pad 2 to adhere to the patients skin close to the opening 12B. The distance between the edge of the opening 12B and the edge of the welding 32 should be at least 2 mm, preferably at least 3 mm, i.e. leaving at least 2 mm, preferably at least 3 mm, of unspoiled adhesive surface on the second surface of the adhesive pad 2 but generally the adhesion between to given materials such as skin and skin compatible adhesive will be improved if the common adhesive surface is large i.e. the larger the better.


Further, the surface plate 1 has a welding position 32 close to the opposite end of the surface plate 1. This welding position 32 is shaped as a mouth or a crescent moon. The function of this rather large welding is to assure that the surface plate 1 will not pivot around the welding and/or other fastening means positioned at the opposite end i.e. the “cannula” end, but will be firmly positioned relative to the adhesive pad 2.


The reference numbers of FIG. 2A refers to similar parts with same numbers as described in FIG. 1A-1C, “similar parts” are parts with same function although not with exactly the same look.


The surface plate 1 of this embodiment is rather large and rigid. That the surface plate is large means that it has a dimension which is more than 3 cm long e.g. the diameter should be at least 3 cm for a round surface plate 1, when the surface plate 1 has credit card size it has a length of at least 8 cm and a width of at least 4 cm, the adhesive pad 2 will be larger than the contact surface of the surface plate, normally the adhesive pad 2 will extend the contact surface with at least 3 mm in all directions i.e. if the contact surface is round and have a diameter of 4 cm the diameter of a round adhesive pad 2 would be at least 4.6 cm and the length/width of a square adhesion pad 2 would be at least 4.6 cm.


The adhesive pad 2 of FIG. 2A-B is provided with a release liner 31; a release liner protects the adhesive surface before use but can easily be peeled of by the user before the base part is to be positioned on the patient's skin. In FIG. 2A which shows the embodiment from above it is only possible to see a handle part of the two-piece release liner 31. Also the embodiment of the base part shown in FIG. 2A is provided with an adhesive part 30 which is shown as secured to the adhesive pad 2. The adhesive part 30 can be a double coated tape. If the adhesive part 30 is placed close to the edge of the adhesive pad 2 which is normally less than 1 mm thick then it would be suitable to apply a tape approved for medial use such as e.g. the tape of type 1517 from 3M. If the adhesive part 30 is placed away from the edge of the adhesive pad 2 it is not important to use a tape approved for medical use as the patient is adequately separated from the tape. But in both cases it should be possible to sterilize the tape or coating as the whole medical device will have to be sterilized before use. Normally gamma radiation or ethylene gas is used to sterilize medical devices, while this makes it desirable that the tape or coating should be able to withstand such sterilization and be able to sustain a sufficient adhesion afterwards. Adhesive parts 30 in the form of medical grade pressure sensitive plastic, non-woven and foam adhesive tapes which are suitable for the present use can be bought commercially.


The adhesive part 30 of the embodiment in FIG. 2A-2D is rectangular and has a T-shaped opening which closely follows the edge of the opening 12B in order to keep the surface plate 1 as firmly positioned in this area as possible.


The surface plate 1 of the embodiment in FIG. 2A-D is not provided with a cannula or another subcutaneous part but the base part is provided with an opening 12A/12B which can receive a cannula or another subcutaneous part 7 and when the medical device is in use the cannula or another subcutaneous part will be positioned in this opening 12A/B.



FIGS. 2E-2G illustrate the use of spot welding when replacing larger continued weldings such as those weldings illustrated in FIGS. 2A-2D. The spot weldings can have the form of small circles or short lines. That the circle is small means that no adhesive effect between skin and pad 2 is achieved within the circle, and that a line is short means that if it was rounded to a circle, i.e. tight together at the ends, no adhesive effect between skin and pad would be achieved within the formed circle.


In FIG. 2E the adhesive pad 2 and the contact surface is provided with two circular spot weldings 32 i.e. one on each side of the opening 12B through which the subcutaneous device passes. The opening 12B is placed close to the edge of the surface plate 1 and an adhesive part 30 is placed around the opening 12B. Further the adhesive pad 2 and the contact surface is provided with two circular spot weldings 32 at the opposite end, i.e. one at each side of the contact surface in order to prevent the surface plate 1 to separate from the adhesive pad 2 and pivot away from the patients skin.


In FIG. 2F the adhesive pad 2 and the contact surface is provided with linear spot weldings 32 i.e. one on each side of the opening 12B through which the subcutaneous device passes. Like in FIG. 2E an adhesive part 30 is placed around the opening 12B. Further the adhesive pad 2 and the contact surface is provided with two linear spot weldings 32 at the opposite end, i.e. one at each side of the contact surface in order to prevent the surface plate 1 to separate from the adhesive pad 2 and pivot away from the patients skin.


In FIG. 2G the adhesive pad 2 and the contact surface is provided with two circular spot weldings 32 i.e. one on each side of the opening 12B through which the subcutaneous device passes. The opening 12B is placed around the middle of the surface plate 1 and an adhesive part 30 is placed around the opening 12B. Further the adhesive pad 2 and the contact surface is provided with two linear spot weldings 32 at each end of the surface plate 1, i.e. one at each side of the contact surface in order to prevent the surface plate 1 to separate from the adhesive pad 2 and pivot away from the patients skin at either end.



FIGS. 3A and 3B illustrates how the invention can be applied when dealing with a smaller medical device i.e. a medical device which has a contact surface smaller than 3 cm in all dimensions parallel to the skin of the patient. The shown embodiments of the adhesive pads 2 are both round having a central opening 12B which makes it possible to insert a subcutaneous part through the adhesive pad 2.



FIG. 3A illustrates an embodiment of the prior art where welding positions 32 (illustrated by 8 fat lines) often are positioned as rays extending from the center to the perimeter at the area between the contact surface of the surface plate 1 and the first surface of the adhesive pad 2. This embodiment assures a very firm attachment between the adhesive pad 2 and the surface plate 1.



FIG. 3B illustrates an embodiment according to the invention where welding positions 32 (illustrated by 4 fat lines) will placed along the edge of the contact surface of the surface plate 1 when the surface plate 1 has been secured to the adhesive pad 2. It is obvious that this embodiment will provide a much large area of adhesion between the adhesive pad 2 and the patient's skin as a smaller area of the adhesive surface will be destroyed by welding. The central opening 12B is surrounded by an adhesive part 30 which will provide adequate adhesion between the surface plate 1 and the adhesive pad 2 despite the smaller welded area.

Claims
  • 1. A medical device comprising: a cannula or another part to be positioned subcutaneously when in use,a surface plate provided with a contact surface and with an opening through which the cannula or another subcutaneously positioned part passes when the medical device is in use,an adhesive pad secured to the contact surface of the surface plate providing adhesion of the surface plate to a skin surface, the adhesive pad comprising: a first surface facing the contact surface and having areas unreleasably secured to the contact surface by welding, anda second surface facing the skin of a patient during use and having areas provided with a skin compatible adhesive which can be releasably secured to the skin of a patient, andan adhesive part placed between the contact surface of the surface plate of the medical device and the first surface of the adhesive pad in an area where the two surfaces have not been welded together thereby securing the unwelded areas of the contact surface to the first surface with the adhesive part together, wherein the adhesive part is positioned along an edge of the opening of the contact surface of the surface plate through which opening the cannula or another subcutaneously positioned part passes, andwherein a welding is placed between the adhesive part and at least one edge of the surface plate.
  • 2. A medical device according to claim 1, wherein the adhesive part comprises a piece of double adhesive material wherein each side of the adhesive part is provided with adhesive coating or the adhesive part comprises a coating of adhesive placed directly on the contact surface of the surface plate or the adhesive part comprises a coating of adhesive placed directly on the first surface of the adhesive pad.
  • 3. A medical device according to claim 1, wherein the adhesive part comprises a piece of double adhesive tape which can be sterilized by either gamma radiation or ethylene oxide gas.
  • 4. A medical device according to claim 1, wherein the adhesive part comprises a piece of double adhesive tape which can sterilized by either gamma radiation or ethylene oxide gas.
  • 5. A medical device according to claim 1, wherein spot weldings are placed on at least two opposite sides of the adhesive part.
  • 6. A medical device according to claim 1, wherein the welding placed between the adhesive part and the at least one edge of the surface plate comprises either a larger circular welding or one or more spot weldings.
  • 7. A medical device according to claim 1, wherein the subcutaneously positioned part is a sensor.
  • 8. The medical device of claim 1, comprising a second welding position at least 2 mm from the first welding position.
  • 9. A base part of a medical device comprising: a surface plate provided with a contact surface and with an opening through which a cannula or another subcutaneously positioned part passes when the medical device is in use, andan adhesive pad secured to the contact surface of the surface plate providing adhesion of the surface plate to a skin surface, the adhesive pad comprising: a first surface facing the contact surface and having areas unreleasably secured to the contact surface by welding, anda second surface facing the skin of a patient during use and having areas provided with a skin compatible adhesive which can be releasably secured to the skin of a patient, andan adhesive part placed between the contact surface of the surface plate of the base part and the first surface of the adhesive pad in an area where the two surfaces have not been welded together thereby securing the unwelded areas of the contact surface to the first surface with the adhesive part, wherein the adhesive part is positioned along an edge of the opening of the contact surface of the surface plate through which opening the cannula or another subcutaneously positioned part passes, andwherein a welding is placed between the adhesive part and at least one edge of the surface plate.
  • 10. An adhesive pad secured to a medical device and providing adhesion of the medical device to a skin surface, the adhesive pad comprising: a first surface facing the medical device having areas unreleasably secured to the medical device by welding,a second surface having areas provided with a skin compatible adhesive which can be releasably secured to the skin of a patient, wherein the first surface has at least one area provided with an adhesive part securing the first surface to the medical device, andan opening for a cannula or another subcutaneously positioned part to pass through, wherein the adhesive part is positioned along an edge of the opening, andwherein a welding is placed between the adhesive part and at least one edge of the first surface.
Priority Claims (1)
Number Date Country Kind
2008 01833 Dec 2008 DK national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/EP2009/067490 12/18/2009 WO 00 8/3/2011
Publishing Document Publishing Date Country Kind
WO2010/072664 7/1/2010 WO A
US Referenced Citations (577)
Number Name Date Kind
1592462 MacGregor Jul 1926 A
2047010 Dickinson Jul 1936 A
2295849 Kayden Sep 1942 A
2690529 Lindblad Sep 1954 A
2972779 Cowley Feb 1961 A
3059802 Mitchell Oct 1962 A
3074541 Roehr Jan 1963 A
3149186 Coanda Sep 1964 A
3221739 Rosenthal Dec 1965 A
3221740 Rosenthal Dec 1965 A
3306291 Burke Feb 1967 A
3485352 Pilger Dec 1969 A
3509879 Bathish et al. May 1970 A
3519158 Anderson Jul 1970 A
3547119 Hall et al. Dec 1970 A
3575337 Bernhardt Apr 1971 A
3610240 Harautuneian Oct 1971 A
3615039 Ward Oct 1971 A
3670727 Reiterman Jun 1972 A
3783895 Weichselbaum Jan 1974 A
3788374 Saijo Jan 1974 A
3810469 Hurschman May 1974 A
3835862 Villari Sep 1974 A
3840011 Wright Oct 1974 A
3893448 Brantigan Jul 1975 A
3937219 Karakashian Feb 1976 A
3986507 Watt Oct 1976 A
3986508 Barrington Oct 1976 A
3995518 Spiroff Dec 1976 A
4022205 Tenczar May 1977 A
4188950 Wardlaw Feb 1980 A
4201406 Dennehey et al. May 1980 A
4227528 Wardlaw Oct 1980 A
4259276 Rawlings Mar 1981 A
4267836 Whitney et al. May 1981 A
4296786 Brignola Oct 1981 A
4315505 Crandall et al. Feb 1982 A
4333455 Bodicky Jun 1982 A
4334551 Pfister Jun 1982 A
D267199 Koenig Dec 1982 S
4378015 Wardlaw Mar 1983 A
4402407 Maly Sep 1983 A
4415393 Grimes Nov 1983 A
4417886 Frankhouser et al. Nov 1983 A
4464178 Dalton Aug 1984 A
4473369 Lueders et al. Sep 1984 A
4484910 Sarnoff et al. Nov 1984 A
4500312 McFarlane Feb 1985 A
4508367 Oreopoulos et al. Apr 1985 A
4525157 Vaillancourt Jun 1985 A
4530695 Phillips et al. Jul 1985 A
4531937 Yates Jul 1985 A
4543088 Bootman et al. Sep 1985 A
4563177 Kamen Jan 1986 A
4610469 Wolff-Mooij Sep 1986 A
4617019 Fecht Oct 1986 A
4713059 Bickelhaupt et al. Dec 1987 A
4734092 Millerd Mar 1988 A
4755173 Konopka et al. Jul 1988 A
4817603 Turner et al. Apr 1989 A
RE32922 Levin et al. May 1989 E
4838871 Luther Jun 1989 A
4840613 Balbierz Jun 1989 A
4850974 Bickelhaupt et al. Jul 1989 A
4850996 Cree Jul 1989 A
4863016 Fong et al. Sep 1989 A
4878897 Katzin Nov 1989 A
4890608 Steer Jan 1990 A
4894054 Miskinyar Jan 1990 A
4895570 Larkin Jan 1990 A
4917669 Bonaldo Apr 1990 A
4935010 Cox et al. Jun 1990 A
4950163 Zimble Aug 1990 A
4950252 Luther et al. Aug 1990 A
4956989 Nakajima Sep 1990 A
4970954 Weir et al. Nov 1990 A
4978338 Melsky et al. Dec 1990 A
4982842 Hollister Jan 1991 A
4986817 Code Jan 1991 A
4994042 Vadher Feb 1991 A
4994045 Ranford Feb 1991 A
5011475 Olson Apr 1991 A
5020665 Bruno Jun 1991 A
5024662 Menes et al. Jun 1991 A
5067496 Eisele Nov 1991 A
5092853 Couvertier, II Mar 1992 A
5098389 Cappucci Mar 1992 A
5112313 Sallee May 1992 A
5116319 Van den Haak May 1992 A
5116325 Paterson May 1992 A
5121751 Panalletta Jun 1992 A
5129884 Dysarz Jul 1992 A
5135502 Koenig, Jr. et al. Aug 1992 A
5137516 Rand et al. Aug 1992 A
5137524 Lynn et al. Aug 1992 A
5141496 Dalto et al. Aug 1992 A
5147375 Sullivan et al. Sep 1992 A
5163915 Holleron Nov 1992 A
5172808 Bruno Dec 1992 A
5176643 Kramer et al. Jan 1993 A
5176650 Haining Jan 1993 A
5176662 Bartholomew et al. Jan 1993 A
5186712 Kelso et al. Feb 1993 A
5188611 Orgain Feb 1993 A
RE34223 Bonaldo Apr 1993 E
5205820 Kriesel Apr 1993 A
5222947 D'Amico Jun 1993 A
5232454 Hollister Aug 1993 A
5248301 Koenig et al. Sep 1993 A
5256149 Banik et al. Oct 1993 A
5256152 Marks Oct 1993 A
5257980 Van Antwerp et al. Nov 1993 A
5267963 Bachynsky Dec 1993 A
5269799 Daniel Dec 1993 A
5271744 Kramer et al. Dec 1993 A
5279579 D'Amico Jan 1994 A
5279591 Simon Jan 1994 A
5282793 Larson Feb 1994 A
5300030 Crossman et al. Apr 1994 A
5312359 Wallace May 1994 A
5312369 Arcusin et al. May 1994 A
5316246 Scott et al. May 1994 A
5324302 Crouse Jun 1994 A
5342319 Watson et al. Aug 1994 A
5342324 Tucker Aug 1994 A
5344007 Nakamura et al. Sep 1994 A
5350392 Purcell et al. Sep 1994 A
5354280 Haber et al. Oct 1994 A
5354337 Hoy Oct 1994 A
5366469 Steg et al. Nov 1994 A
5372592 Gambale Dec 1994 A
5372787 Ritter Dec 1994 A
5376082 Phelps Dec 1994 A
5379895 Foslien Jan 1995 A
5384174 Ward et al. Jan 1995 A
5387197 Smith et al. Feb 1995 A
5390669 Stuart et al. Feb 1995 A
5391151 Wilmot Feb 1995 A
5403288 Stanners Apr 1995 A
5405332 Opalek Apr 1995 A
5425715 Dalling et al. Jun 1995 A
5429607 McPhee Jul 1995 A
5429613 D'Amico Jul 1995 A
5439473 Jorgensen Aug 1995 A
D362718 Deily et al. Sep 1995 S
5449349 Sallee et al. Sep 1995 A
5451210 Kramer et al. Sep 1995 A
5478316 Bitdinger et al. Dec 1995 A
5490841 Landis Feb 1996 A
5501675 Erskine Mar 1996 A
5505709 Funderburk et al. Apr 1996 A
5507730 Haber et al. Apr 1996 A
5514117 Lynn May 1996 A
5520654 Wahlberg May 1996 A
5522803 Teissen-Simony Jun 1996 A
5527287 Miskinyar et al. Jun 1996 A
5533974 Gaba Jul 1996 A
5540709 Ramel Jul 1996 A
5545143 Fischell Aug 1996 A
5545152 Funderburk et al. Aug 1996 A
5549577 Siegel et al. Aug 1996 A
5554130 McDonald et al. Sep 1996 A
5558650 McPhee Sep 1996 A
5562629 Haughton et al. Oct 1996 A
5562636 Utterberg Oct 1996 A
5573510 Isaacson Nov 1996 A
5575777 Cover et al. Nov 1996 A
5584813 Livingston et al. Dec 1996 A
5586553 Halili Dec 1996 A
5591188 Waisman Jan 1997 A
5599309 Marshall et al. Feb 1997 A
5599315 McPhee Feb 1997 A
5599318 Sweeney et al. Feb 1997 A
5628765 Morita May 1997 A
5643214 Marshall et al. Jul 1997 A
5643216 White Jul 1997 A
5643220 Cosme Jul 1997 A
5658256 Shields Aug 1997 A
5662617 Odell et al. Sep 1997 A
5665071 Wyrick Sep 1997 A
5665075 Gyure et al. Sep 1997 A
5676156 Yoon Oct 1997 A
5681323 Arick Oct 1997 A
5695476 Harris Dec 1997 A
5697907 Gaba Dec 1997 A
5700250 Erskine Dec 1997 A
5702371 Bierman Dec 1997 A
5704920 Gyure Jan 1998 A
5709662 Olive et al. Jan 1998 A
5714225 Hansen et al. Feb 1998 A
5738641 Watson et al. Apr 1998 A
5741288 Rife Apr 1998 A
5752923 Terwilliger May 1998 A
5807316 Teeple Sep 1998 A
5807348 Zinger et al. Sep 1998 A
5810835 Ryan et al. Sep 1998 A
5817058 Shaw Oct 1998 A
5820598 Gazza et al. Oct 1998 A
5827236 Takahashi Oct 1998 A
5833666 Davis et al. Nov 1998 A
5843001 Goldenberg Dec 1998 A
5848990 Cirelli et al. Dec 1998 A
5851197 Marano et al. Dec 1998 A
5858001 Tsals et al. Jan 1999 A
5865806 Howell Feb 1999 A
5899886 Cosme May 1999 A
5911705 Howell Jun 1999 A
5913846 Szabo Jun 1999 A
5916199 Miles Jun 1999 A
5919167 Mulhauser et al. Jul 1999 A
5919170 Woessner Jul 1999 A
5925032 Clements Jul 1999 A
5935109 Donnan Aug 1999 A
5947931 Bierman Sep 1999 A
5947935 Rinehart et al. Sep 1999 A
5951523 Osterlind et al. Sep 1999 A
5954643 VanAntwerp et al. Sep 1999 A
5957892 Thorne Sep 1999 A
5957897 Jeffrey Sep 1999 A
5968011 Larsen et al. Oct 1999 A
5971966 Lav Oct 1999 A
5975120 Novosel Nov 1999 A
5980488 Thorne Nov 1999 A
5980506 Mathiasen Nov 1999 A
5984224 Yang Nov 1999 A
5984897 Petersen et al. Nov 1999 A
D417733 Howell et al. Dec 1999 S
6017328 Fischell et al. Jan 2000 A
6017598 Kreischer et al. Jan 2000 A
D421119 Musgrave et al. Feb 2000 S
6024727 Thorne et al. Feb 2000 A
6039629 Mitchell Mar 2000 A
6042570 Bell et al. Mar 2000 A
6045533 Kriesel et al. Apr 2000 A
6045534 Jacobsen et al. Apr 2000 A
6050976 Thorne et al. Apr 2000 A
6053893 Bucher Apr 2000 A
6053930 Ruppert Apr 2000 A
6056718 Funderburk et al. May 2000 A
6056726 Isaacson May 2000 A
6074369 Sage et al. Jun 2000 A
6074371 Fischell Jun 2000 A
6077244 Botich et al. Jun 2000 A
6079432 Paradis Jun 2000 A
6086008 Gray et al. Jul 2000 A
6086575 Mejslov Jul 2000 A
6090068 Chanut Jul 2000 A
6093172 Funderburk et al. Jul 2000 A
6093179 O'Hara et al. Jul 2000 A
6099503 Stardella Aug 2000 A
6105218 Reekie Aug 2000 A
6106498 Friedli et al. Aug 2000 A
6120482 Szabo Sep 2000 A
6123690 Mejslov Sep 2000 A
6132755 Eicher et al. Oct 2000 A
6139534 Niedospial, Jr. Oct 2000 A
6159181 Crossman et al. Dec 2000 A
6183464 Sharp et al. Feb 2001 B1
6191338 Haller Feb 2001 B1
6193694 Bell et al. Feb 2001 B1
6210420 Mauze et al. Apr 2001 B1
6219574 Cormier et al. Apr 2001 B1
6221058 Kao et al. Apr 2001 B1
6248093 Moberg Jun 2001 B1
6261272 Gross et al. Jul 2001 B1
6293925 Safabash et al. Sep 2001 B1
6302866 Marggi Oct 2001 B1
6319232 Kashmer Nov 2001 B1
6322535 Hitchins et al. Nov 2001 B1
6322808 Trautman et al. Nov 2001 B1
6334856 Allen et al. Jan 2002 B1
6355021 Nielsen et al. Mar 2002 B1
6364113 Faasse et al. Apr 2002 B1
6378218 Sigwart et al. Apr 2002 B2
6379335 Rigon et al. Apr 2002 B1
6387076 Landuyt May 2002 B1
6387078 Gillespie, III May 2002 B1
6405876 Seshimoto et al. Jun 2002 B1
6440096 Lastovich et al. Aug 2002 B1
6447482 Rønborg et al. Sep 2002 B1
6450992 Cassidy, Jr. Sep 2002 B1
6485461 Mason et al. Nov 2002 B1
6488663 Steg Dec 2002 B1
6503222 Lo Jan 2003 B2
6517517 Farrugia et al. Feb 2003 B1
6520938 Funderburk et al. Feb 2003 B1
D472316 Douglas et al. Mar 2003 S
D472630 Douglas et al. Apr 2003 S
6572586 Wojcik Jun 2003 B1
6579267 Lynch et al. Jun 2003 B2
6582397 Alesi et al. Jun 2003 B2
6595962 Perthu Jul 2003 B1
6607509 Bobroff et al. Aug 2003 B2
6607511 Halseth et al. Aug 2003 B2
6613064 Rutynowski et al. Sep 2003 B2
6620133 Steck Sep 2003 B1
6620136 Pressly, Sr. et al. Sep 2003 B1
6620140 Metzger Sep 2003 B1
6629949 Douglas Oct 2003 B1
6645181 Lavi et al. Nov 2003 B1
6645182 Szabo Nov 2003 B1
6659982 Douglas et al. Dec 2003 B2
6685674 Douglas et al. Feb 2004 B2
6689100 Connelly et al. Feb 2004 B2
6699218 Flaherty et al. Mar 2004 B2
6702779 Connelly et al. Mar 2004 B2
6726649 Swenson et al. Apr 2004 B2
6736797 Larsen et al. May 2004 B1
6743203 Pickhard Jun 2004 B1
6749587 Flaherty Jun 2004 B2
6749589 Douglas et al. Jun 2004 B1
6755805 Reid Jun 2004 B1
6776775 Mohammad Aug 2004 B1
6790199 Gianakos Sep 2004 B1
6805686 Fathallah et al. Oct 2004 B1
6808506 Lastovich et al. Oct 2004 B2
6811545 Vaillancourt Nov 2004 B2
6814720 Olsen et al. Nov 2004 B2
6824530 Wagner et al. Nov 2004 B2
6824531 Zecha, Jr. et al. Nov 2004 B1
6830562 Mogensen et al. Dec 2004 B2
6837877 Zurcher Jan 2005 B2
6837878 Smutney et al. Jan 2005 B2
6840922 Nielsen et al. Jan 2005 B2
6880701 Bergeron et al. Apr 2005 B2
6923791 Douglas Aug 2005 B2
6926694 Marano-Ford et al. Aug 2005 B2
6939324 Gonnelli et al. Sep 2005 B2
6939331 Ohshima Sep 2005 B2
6949084 Marggi et al. Sep 2005 B2
6959812 Reif et al. Nov 2005 B2
6960193 Rosenberg Nov 2005 B2
6979316 Rubin et al. Dec 2005 B1
6991619 Marano-Ford et al. Jan 2006 B2
6991620 Marano-Ford et al. Jan 2006 B2
6994213 Giard et al. Feb 2006 B2
6997907 Safabash et al. Feb 2006 B2
7014625 Bengtsson Mar 2006 B2
7018344 Bressler et al. Mar 2006 B2
7022108 Marano-Ford et al. Apr 2006 B2
7047070 Wilkinson et al. May 2006 B2
7052483 Wojcik May 2006 B2
7055713 Rea et al. Jun 2006 B2
7056302 Douglas Jun 2006 B2
7070580 Nielsen Jul 2006 B2
7074208 Pajunk et al. Jul 2006 B2
D526409 Nielsen et al. Aug 2006 S
7083592 Lastovich et al. Aug 2006 B2
7083597 Lynch et al. Aug 2006 B2
7097631 Trautman et al. Aug 2006 B2
7109878 Mann et al. Sep 2006 B2
7115108 Wilkenson et al. Oct 2006 B2
7115112 Mogensen et al. Oct 2006 B2
7137968 Burrell et al. Nov 2006 B1
7141023 Diermann et al. Nov 2006 B2
7147623 Mathiasen Dec 2006 B2
7186236 Gibson et al. Mar 2007 B2
7211068 Douglas May 2007 B2
7214207 Lynch et al. May 2007 B2
7214215 Heinzerling et al. May 2007 B2
7250037 Shermer et al. Jul 2007 B2
7258680 Mogensen et al. Aug 2007 B2
D554253 Kornerup Oct 2007 S
7303543 Maule et al. Dec 2007 B1
7309326 Fangrow, Jr. Dec 2007 B2
7322473 Fux Jan 2008 B2
7407491 Fangrow, Jr. Aug 2008 B2
7407493 Cane′ Aug 2008 B2
7431876 Mejlhede et al. Oct 2008 B2
7441655 Hoftman Oct 2008 B1
7569262 Szabo et al. Aug 2009 B2
7648494 Kornerup et al. Jan 2010 B2
7766867 Lynch et al. Aug 2010 B2
7846132 Gravesen et al. Dec 2010 B2
7850652 Liniger et al. Dec 2010 B2
8012126 Tipsmark et al. Sep 2011 B2
8087333 Oishi Jan 2012 B2
8123724 Gillespie, III Feb 2012 B2
8303549 Mejlhede et al. Nov 2012 B2
8323250 Chong et al. Dec 2012 B2
20010004970 Hollister et al. Jun 2001 A1
20010016714 Bell et al. Aug 2001 A1
20010021827 Ferguson et al. Sep 2001 A1
20010039387 Rutynowski et al. Nov 2001 A1
20010039401 Ferguson et al. Nov 2001 A1
20010041875 Higuchi et al. Nov 2001 A1
20010049496 Kirchhofer Dec 2001 A1
20010053889 Marggi Dec 2001 A1
20010056284 Purcell et al. Dec 2001 A1
20020022798 Connelly Feb 2002 A1
20020022855 Bobroff et al. Feb 2002 A1
20020026152 Bierman Feb 2002 A1
20020055711 Lavi et al. May 2002 A1
20020068904 Bierman et al. Jun 2002 A1
20020072720 Hague et al. Jun 2002 A1
20020074345 Schneider et al. Jun 2002 A1
20020077599 Wojcik Jun 2002 A1
20020082543 Park et al. Jun 2002 A1
20020107489 Lee Aug 2002 A1
20020111581 Sasso Aug 2002 A1
20020156424 Suzuki et al. Oct 2002 A1
20020156427 Suzuki et al. Oct 2002 A1
20020161322 Utterberg et al. Oct 2002 A1
20020161332 Ramey Oct 2002 A1
20020161386 Halseth et al. Oct 2002 A1
20020165493 Bierman Nov 2002 A1
20020169419 Steg Nov 2002 A1
20020173748 McConnell et al. Nov 2002 A1
20020173769 Gray et al. Nov 2002 A1
20020183688 Lastovich et al. Dec 2002 A1
20020189688 Roorda Dec 2002 A1
20020193737 Popovsky Dec 2002 A1
20020193744 Alesi et al. Dec 2002 A1
20030014018 Giambattista et al. Jan 2003 A1
20030060781 Mogensen et al. Mar 2003 A1
20030069548 Connelly et al. Apr 2003 A1
20030088238 Poulsen et al. May 2003 A1
20030105430 Lavi et al. Jun 2003 A1
20030109829 Mogensen et al. Jun 2003 A1
20030125669 Safabash et al. Jul 2003 A1
20030125678 Swenson et al. Jul 2003 A1
20030130619 Safabash et al. Jul 2003 A1
20030139704 Lin Jul 2003 A1
20030158520 Safabash et al. Aug 2003 A1
20030176843 Wilkinson Sep 2003 A1
20030176852 Lynch et al. Sep 2003 A1
20030181863 Ackley et al. Sep 2003 A1
20030181868 Swenson Sep 2003 A1
20030181873 Swenson Sep 2003 A1
20030181874 Bressler et al. Sep 2003 A1
20030187394 Wilkinson et al. Oct 2003 A1
20030187395 Gabel Oct 2003 A1
20030199823 Bobroff et al. Oct 2003 A1
20030216686 Lynch et al. Nov 2003 A1
20030220610 Lastovich et al. Nov 2003 A1
20030225373 Bobroff et al. Dec 2003 A1
20030225374 Mathiasen Dec 2003 A1
20030229308 Tsals et al. Dec 2003 A1
20030229316 Hwang et al. Dec 2003 A1
20040002682 Kovelman et al. Jan 2004 A1
20040006316 Patton Jan 2004 A1
20040044306 Lynch et al. Mar 2004 A1
20040049159 Barrus et al. Mar 2004 A1
20040055711 Martin et al. Mar 2004 A1
20040059316 Smedegaard Mar 2004 A1
20040068231 Blondeau Apr 2004 A1
20040069044 Lavi et al. Apr 2004 A1
20040087913 Rogers et al. May 2004 A1
20040092865 Flaherty et al. May 2004 A1
20040092875 Kochamba May 2004 A1
20040111068 Swenson Jun 2004 A1
20040112781 Hofverberg et al. Jun 2004 A1
20040116865 Bengtsson Jun 2004 A1
20040133164 Funderburk et al. Jul 2004 A1
20040138612 Shermer et al. Jul 2004 A1
20040138620 Douglas et al. Jul 2004 A1
20040143216 Douglas et al. Jul 2004 A1
20040143218 Das Jul 2004 A1
20040158202 Jensen Aug 2004 A1
20040158207 Hunn et al. Aug 2004 A1
20040162518 Connelly et al. Aug 2004 A1
20040162521 Bengtsson Aug 2004 A1
20040171989 Horner et al. Sep 2004 A1
20040178098 Swenson et al. Sep 2004 A1
20040186446 Ohshima Sep 2004 A1
20040193143 Sauer Sep 2004 A1
20040199123 Nielsen Oct 2004 A1
20040204673 Flaherty et al. Oct 2004 A1
20040204687 Mogensen et al. Oct 2004 A1
20040204690 Yashiro et al. Oct 2004 A1
20040215151 Marshall et al. Oct 2004 A1
20040220528 Garcia, Jr. Nov 2004 A1
20040236284 Hoste et al. Nov 2004 A1
20040238392 Peterson et al. Dec 2004 A1
20040243065 McConnell et al. Dec 2004 A1
20040254433 Bandis et al. Dec 2004 A1
20040260235 Douglas Dec 2004 A1
20040260250 Harris et al. Dec 2004 A1
20050035014 Cane Feb 2005 A1
20050038378 Lastovich et al. Feb 2005 A1
20050043687 Mogensen et al. Feb 2005 A1
20050049571 Lastovich et al. Mar 2005 A1
20050065466 Vedrine Mar 2005 A1
20050065472 Cindrich et al. Mar 2005 A1
20050075606 Botich et al. Apr 2005 A1
20050080386 Reid Apr 2005 A1
20050101910 Bowman et al. May 2005 A1
20050101912 Faust et al. May 2005 A1
20050101932 Cote et al. May 2005 A1
20050101933 Marrs et al. May 2005 A1
20050107743 Fangrow May 2005 A1
20050113761 Faust et al. May 2005 A1
20050119611 Marano-Ford et al. Jun 2005 A1
20050119619 Haining Jun 2005 A1
20050119637 Lundgren et al. Jun 2005 A1
20050124936 Mogensen et al. Jun 2005 A1
20050131347 Marano-Ford et al. Jun 2005 A1
20050159709 Wilkinson Jul 2005 A1
20050159714 Gibson Jul 2005 A1
20050165382 Fulford Jul 2005 A1
20050192560 Walls et al. Sep 2005 A1
20050203461 Flaherty et al. Sep 2005 A1
20050215979 Kornerup et al. Sep 2005 A1
20050240154 Mogensen et al. Oct 2005 A1
20050251098 Wyss et al. Nov 2005 A1
20050256456 Marano-Ford et al. Nov 2005 A1
20050261629 Marano-Ford et al. Nov 2005 A1
20050277892 Chen Dec 2005 A1
20050283114 Bresina et al. Dec 2005 A1
20060015063 Butikofer et al. Jan 2006 A1
20060015076 Heinzerling et al. Jan 2006 A1
20060030815 Csincsura et al. Feb 2006 A1
20060036214 Mogensen et al. Feb 2006 A1
20060041224 Jensen Feb 2006 A1
20060069351 Safabash et al. Mar 2006 A9
20060069382 Pedersen Mar 2006 A1
20060069383 Bogaerts et al. Mar 2006 A1
20060095003 Marano-Ford et al. May 2006 A1
20060095014 Ethelfeld May 2006 A1
20060106346 Sullivan et al. May 2006 A1
20060129123 Wojcik Jun 2006 A1
20060135908 Liniger et al. Jun 2006 A1
20060135913 Ethelfeld Jun 2006 A1
20060142698 Ethelfeld Jun 2006 A1
20060161108 Mogensen et al. Jul 2006 A1
20060173410 Moberg et al. Aug 2006 A1
20060173413 Fan Aug 2006 A1
20060184104 Cheney, II et al. Aug 2006 A1
20060184140 Okiyama Aug 2006 A1
20060200073 Radmer et al. Sep 2006 A1
20060241551 Lynch et al. Oct 2006 A1
20060247553 Diermann et al. Nov 2006 A1
20060247574 Maule et al. Nov 2006 A1
20060253085 Geismar et al. Nov 2006 A1
20060253086 Moberg et al. Nov 2006 A1
20060264835 Nielsen et al. Nov 2006 A1
20060264890 Moberg et al. Nov 2006 A1
20070005017 Alchas et al. Jan 2007 A1
20070016129 Liniger et al. Jan 2007 A1
20070016159 Sparholt et al. Jan 2007 A1
20070021729 Mogensen et al. Jan 2007 A1
20070049865 Radmer et al. Mar 2007 A1
20070049870 Gray et al. Mar 2007 A1
20070051784 Money et al. Mar 2007 A1
20070066955 Sparholt et al. Mar 2007 A1
20070066958 Wright Mar 2007 A1
20070088271 Richards et al. Apr 2007 A1
20070093754 Mogensen Apr 2007 A1
20070104596 Preuthun et al. May 2007 A1
20070112301 Preuthun et al. May 2007 A1
20070112303 Liniger May 2007 A1
20070129688 Scheurer et al. Jun 2007 A1
20070129691 Sage, Jr. et al. Jun 2007 A1
20070173767 Lynch et al. Jul 2007 A1
20070179444 Causey et al. Aug 2007 A1
20070185441 Fangrow, Jr. Aug 2007 A1
20070191772 Wojcik Aug 2007 A1
20070191773 Wojcik Aug 2007 A1
20070203454 Shermer et al. Aug 2007 A1
20070213673 Douglas Sep 2007 A1
20070244448 Lastovich et al. Oct 2007 A1
20070282269 Carter et al. Dec 2007 A1
20070299409 Whitbourne et al. Dec 2007 A1
20080058692 Propp et al. Mar 2008 A1
20080119707 Stafford May 2008 A1
20080200897 Hoss et al. Aug 2008 A1
20080269687 Chong Oct 2008 A1
20080312601 Cane′ Dec 2008 A1
20090062767 Van Antwerp et al. Mar 2009 A1
20090118592 Klitgaard May 2009 A1
20090326456 Cross et al. Dec 2009 A1
20100004597 Gyrn et al. Jan 2010 A1
20100022956 Tipsmark et al. Jan 2010 A1
20100137829 Nielsen et al. Jun 2010 A1
20100228226 Nielsen Sep 2010 A1
20100262078 Blomquist Oct 2010 A1
20110054399 Chong et al. Mar 2011 A1
Foreign Referenced Citations (205)
Number Date Country
4 342 329 Jun 1994 DE
196 31 921 Mar 1997 DE
299 05 072 Sep 1999 DE
101 17 285 Nov 2002 DE
203 20 207 Nov 2004 DE
0117632 Sep 1984 EP
0239244 Feb 1987 EP
0272530 Jul 1988 EP
0451040 Oct 1991 EP
0544837 Jun 1993 EP
0615768 Sep 1994 EP
0651662 May 1995 EP
0652027 May 1995 EP
0657184 Jun 1995 EP
0688232 Dec 1995 EP
0714631 Jul 1996 EP
0744183 Nov 1996 EP
0747006 Dec 1996 EP
0775501 May 1997 EP
0799626 Oct 1997 EP
0937475 Aug 1999 EP
0956879 Nov 1999 EP
2272559 Jan 2001 EP
1086718 Mar 2001 EP
1125593 Aug 2001 EP
1329233 Jul 2003 EP
1350537 Oct 2003 EP
1360970 Nov 2003 EP
1380315 Jan 2004 EP
1407747 Apr 2004 EP
1407793 Apr 2004 EP
1421968 May 2004 EP
1177802 Sep 2004 EP
1475113 Nov 2004 EP
1495775 Jan 2005 EP
1502613 Feb 2005 EP
1525873 Apr 2005 EP
1527792 May 2005 EP
1559442 Aug 2005 EP
1616594 Jan 2006 EP
1704889 Sep 2006 EP
1 719 537 Nov 2006 EP
1762259 Mar 2007 EP
1764125 Mar 2007 EP
1776980 Apr 2007 EP
1970091 Sep 2008 EP
2725902 Oct 1994 FR
2 752 164 Feb 1998 FR
906574 Sep 1962 GB
2 088 215 Jul 1982 GB
2 230 702 Oct 1990 GB
2 423 267 Aug 2006 GB
2 450 872 Jul 2007 GB
2 459 101 Oct 2009 GB
10179734 Aug 1991 JP
7051251 Nov 1995 JP
8187286 Jul 1996 JP
A-03-191965 Jul 1998 JP
2002-028246 Jan 2002 JP
933 100 Jun 1982 RU
2 238 111 Dec 2003 RU
WO 8101795 Jul 1981 WO
WO 8203558 Oct 1982 WO
WO 9204062 Mar 1992 WO
WO 9305840 Apr 1993 WO
WO 9311709 Jun 1993 WO
WO 9420160 Sep 1994 WO
WO 9519194 Jul 1995 WO
WO 9632981 Jul 1996 WO
WO 9620021 Oct 1996 WO
WO 9826835 Jun 1998 WO
WO 9833549 Aug 1998 WO
WO 9858693 Dec 1998 WO
WO 9907435 Feb 1999 WO
WO 9922789 May 1999 WO
WO 9933504 Jul 1999 WO
WO 0002614 Jan 2000 WO
WO 0003757 Jan 2000 WO
WO 0044324 Aug 2000 WO
WO 0112746 Feb 2001 WO
WO 0130419 May 2001 WO
WO 0168180 Sep 2001 WO
WO 0172353 Oct 2001 WO
WO 0176684 Oct 2001 WO
WO 0193926 Dec 2001 WO
WO 0202165 Jan 2002 WO
WO 0207804 Jan 2002 WO
WO 0240083 May 2002 WO
WO 02053220 Jul 2002 WO
WO 02068014 Sep 2002 WO
WO 02081012 Oct 2002 WO
WO 02081013 Oct 2002 WO
WO 02083206 Oct 2002 WO
WO 02083228 Oct 2002 WO
WO 02094352 Nov 2002 WO
WO 02100457 Dec 2002 WO
WO 02102442 Dec 2002 WO
WO 03015860 Feb 2003 WO
WO 03026728 Apr 2003 WO
WO 03068305 Aug 2003 WO
WO 03075980 Sep 2003 WO
WO 03095003 Nov 2003 WO
WO 2004012796 Feb 2004 WO
WO 2004024219 Mar 2004 WO
WO 2004026375 Apr 2004 WO
WO 2004029457 Apr 2004 WO
WO 2004030726 Apr 2004 WO
WO 2004037325 May 2004 WO
WO 2004054644 Jul 2004 WO
WO 2004056412 Jul 2004 WO
WO 2004064593 Aug 2004 WO
WO 2004071308 Aug 2004 WO
WO 2004087240 Oct 2004 WO
WO 2004098683 Nov 2004 WO
WO 2004101016 Nov 2004 WO
WO 2004101071 Nov 2004 WO
WO 2004110527 Dec 2004 WO
WO 2005002649 Jan 2005 WO
WO 2005004973 Jan 2005 WO
WO 2005018703 Mar 2005 WO
WO 2005037184 Apr 2005 WO
WO 2005037350 Apr 2005 WO
WO 2005039673 May 2005 WO
WO 2005046780 May 2005 WO
WO 2005065748 Jul 2005 WO
WO 2005068006 Jul 2005 WO
WO 2005072795 Aug 2005 WO
WO 2005092410 Oct 2005 WO
WO 2005094920 Oct 2005 WO
WO 2005112800 Dec 2005 WO
WO 2005118055 Dec 2005 WO
WO 2006003130 Jan 2006 WO
WO 2006015507 Feb 2006 WO
WO 2006015600 Feb 2006 WO
WO 2006024650 Mar 2006 WO
WO 2006032689 Mar 2006 WO
WO 2006032692 Mar 2006 WO
WO 2006061027 Jun 2006 WO
WO 2006061354 Jun 2006 WO
WO 2006062680 Jun 2006 WO
WO 2006062912 Jun 2006 WO
WO 2006075016 Jul 2006 WO
WO 2006077262 Jul 2006 WO
WO 2006077263 Jul 2006 WO
WO 2006089958 Aug 2006 WO
WO 2006097111 Sep 2006 WO
WO 2006108775 Oct 2006 WO
WO 2006120253 Nov 2006 WO
WO 2006121921 Nov 2006 WO
WO 2006122048 Nov 2006 WO
WO 2007000162 Jan 2007 WO
WO 2007002523 Jan 2007 WO
WO 2007020090 Feb 2007 WO
WO 2007065944 Jun 2007 WO
WO 2007071255 Jun 2007 WO
WO 2007071258 Jun 2007 WO
WO 2007093051 Aug 2007 WO
WO 2007093182 Aug 2007 WO
WO 2007122207 Nov 2007 WO
WO 2007140631 Dec 2007 WO
WO 2007140783 Dec 2007 WO
WO 2007140785 Dec 2007 WO
WO 2007141210 Dec 2007 WO
WO 2008014791 Feb 2008 WO
WO 2008014792 Feb 2008 WO
WO 2008133702 Mar 2008 WO
WO 2008048631 Apr 2008 WO
WO 2008052545 May 2008 WO
WO 2008065646 Jun 2008 WO
WO 2008092782 Aug 2008 WO
WO 2008092958 Aug 2008 WO
WO 2008092959 Aug 2008 WO
WO 2008135098 Nov 2008 WO
WO 2008147600 Dec 2008 WO
WO 2008148714 Dec 2008 WO
WO 2008155145 Dec 2008 WO
WO 2008155377 Dec 2008 WO
WO 2009004026 Jan 2009 WO
WO 2009007287 Jan 2009 WO
WO 2009010396 Jan 2009 WO
WO 2009010399 Jan 2009 WO
WO 2009016635 Feb 2009 WO
WO 2009033032 Mar 2009 WO
WO 2009039013 Mar 2009 WO
WO 2009098291 Aug 2009 WO
WO 2009098306 Aug 2009 WO
WO 2009101130 Aug 2009 WO
WO 2009101145 Aug 2009 WO
WO 2009103759 Aug 2009 WO
WO 2009106517 Sep 2009 WO
WO 2009144272 Dec 2009 WO
WO 2010003885 Jan 2010 WO
WO 2010003886 Jan 2010 WO
WO 2010030602 Mar 2010 WO
WO 2010034830 Apr 2010 WO
WO 2010072664 Jul 2010 WO
WO 2010080715 Jul 2010 WO
WO 2010112521 Oct 2010 WO
WO 2011012465 Feb 2011 WO
WO 2011015659 Feb 2011 WO
WO 2011121023 Oct 2011 WO
WO 2012041784 Apr 2012 WO
WO 2012041923 Apr 2012 WO
WO 2012045667 Apr 2012 WO
WO 2012107440 Aug 2012 WO
Non-Patent Literature Citations (3)
Entry
“Why inset®?” inset® infusion set product overview; http://web.archive.org/web/20040906102448/http://www.infusion-set.com/Default.asp?ID=108; two pages, Jan. 9, 2008.
International Search Report completed Mar. 24, 2010 for International Application No. PCT/EP2009/067490.
Written Opinion completed Mar. 24, 2010 for International Application No. PCT/EP2009/067490.
Related Publications (1)
Number Date Country
20110282293 A1 Nov 2011 US